L26/P-638 Genetic variants associated with reduced embryo viability occur independently of morphology and ploidy and may inform embryo transfer decisions
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von K. Ready und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do reduced viability variants (RVVs) identified by whole genome sequencing occur independently of morphology and ploidy and at a frequency relevant to clinical transfer decisions? Summary answer RVVs were detected in approximately one-third of embryos and were independent of morphology and ploidy, suggesting they could be used to inform embryo transfer decisions. What is known already Approximately 45% of euploid embryo transfers fail, indicating that current embryo selection strategies based on morphology and ploidy do not fully predict transfer success. We previously demonstrated that whole genome sequencing can identify genetic variants associated with reduced embryo viability. These reduced viability variants (RVVs) are supported by biological and human genetic evidence in early embryonic development and pregnancy loss. In a smaller, research-use-only cohort, RVVs were identified in 40% of donated surplus embryos. Evaluating their independence from morphology and ploidy and their frequency in larger clinical cohorts is necessary to continue to assess their potential utility in transfer decisions. Study design, size, duration This study was a retrospective cohort analysis of 218 embryos from 35 families who elected PGT with whole genome sequencing during the course of their IVF treatment. The distribution of euploid embryos with and without reduced viability variants was documented at the embryo and family levels in order to determine potential implications for clinical decision making. Participants/materials, setting, methods Embryos were evaluated for RVVs, morphology, and ploidy status. Variant annotation was conducted using computational evidence from human data resources and published literature. Embryo morphology (reported by the referring clinic) was categorized into high-, intermediate-, and low-quality tiers using combined blastocyst stage and ICM/TE morphology. Associations between RVVs, embryo morphology, and ploidy were determined using chi-square testing. Main results and the role of chance RVVs were detected in 31.9% (67/210) of embryos with available RVV data. Overall, 54.8% (119/217) of embryos were euploid and 40.1% (87/217) were aneuploid. RVV detection did not differ across embryo morphology categories stratified by combined blastocyst stage and ICM/TE quality (χ² = 1.77, p = 0.41). Similarly, RVVs were not more common in aneuploid compared with euploid embryos (30.5% vs 32.8%; χ² = 0.04, p = 0.84), indicating that RVVs segregate independently of ploidy. The median number of embryos tested per family was 4 (range 1–31). Among tested embryos, families had a median of 4 euploid embryos available (IQR 2–9), of which a median of 3 were euploid embryos without RVVs (IQR 2–5). These medians were unchanged after exclusion of the family with the largest number of embryos, indicating that results were not driven by outliers. Importantly, 94% of families had at least one euploid embryo without RVVs, and 73% had multiple, supporting the feasibility of incorporating RVV information into embryo transfer decisions without substantially reducing transfer options. Limitations, reasons for caution This was a retrospective analysis and pregnancy and live birth outcomes were not available. Observational studies evaluating these outcomes following transfers informed by RVV status are ongoing. Wider implications of the findings RVVs identify a subset of euploid embryos with potentially reduced viability that cannot be identified using morphology or ploidy alone. The independent occurrence and consistent frequency of RVVs in a larger clinical cohort supports their potential incorporation into embryo prioritization strategies. Trial registration number No
Zitieren
APA
Ready, K., Reeves, G., Cole, C., Twist, G., Shah, M., Petropoulos, S., Chao, E., Shulman, L., & Grushcow, J. (2026). L26/P-638 Genetic variants associated with reduced embryo viability occur independently of morphology and ploidy and may inform embryo transfer decisions. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.968
Vancouver
Ready K, Reeves G, Cole C, Twist G, Shah M, Petropoulos S, et al. L26/P-638 Genetic variants associated with reduced embryo viability occur independently of morphology and ploidy and may inform embryo transfer decisions. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.968
BibTeX
@article{Ready2026,
author = {Ready, K. and Reeves, G.A. and Cole, C. and Twist, G. and Shah, M. and Petropoulos, S. and Chao, E. and Shulman, L. and Grushcow, J.},
title = {L26/P-638 Genetic variants associated with reduced embryo viability occur independently of morphology and ploidy and may inform embryo transfer decisions},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.968}
}
EUVIMED